Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma.
Guo M, Sun D, Fan Z, Yuan Y, Shao M, Hou J, Zhu Y, Wei R, Zhu Y, Qian J, Li F, Yang Y, Gu C.
Guo M, et al.
Front Oncol. 2019 Aug 8;9:722. doi: 10.3389/fonc.2019.00722. eCollection 2019.
Front Oncol. 2019.
PMID: 31440466
Free PMC article.